Form 8-K - Current report:
SEC Accession No. 0001193125-25-158211
Filing Date
2025-07-11
Accepted
2025-07-11 16:25:19
Documents
13
Period of Report
2025-07-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d915297d8k.htm   iXBRL 8-K 29529
  Complete submission text file 0001193125-25-158211.txt   178594

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nams-20250711.xsd EX-101.SCH 3568
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20250711_def.xml EX-101.DEF 13772
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20250711_lab.xml EX-101.LAB 22356
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20250711_pre.xml EX-101.PRE 14560
15 EXTRACTED XBRL INSTANCE DOCUMENT d915297d8k_htm.xml XML 5721
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 251119269
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)